Cargando…
Primary care and referring physician perspectives on non-alcoholic fatty liver disease management: a nationwide survey
INTRODUCTION: The optimal approach to screening and risk stratification for non-alcoholic fatty liver disease is challenging given disease burden and variable progression. The aim of this study was to assess primary care physician and referring physician practice patterns regarding non-alcoholic fat...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460969/ https://www.ncbi.nlm.nih.gov/pubmed/34567270 http://dx.doi.org/10.1177/17562848211042200 |
_version_ | 1784571877197348864 |
---|---|
author | Saeed, Naba Glass, Lisa M. Habbal, Heba Mahmood, Asad Sengstock, David Saini, Sameer D. Tincopa, Monica A. |
author_facet | Saeed, Naba Glass, Lisa M. Habbal, Heba Mahmood, Asad Sengstock, David Saini, Sameer D. Tincopa, Monica A. |
author_sort | Saeed, Naba |
collection | PubMed |
description | INTRODUCTION: The optimal approach to screening and risk stratification for non-alcoholic fatty liver disease is challenging given disease burden and variable progression. The aim of this study was to assess primary care physician and referring physician practice patterns regarding non-alcoholic fatty liver disease. METHODS: An anonymous nationwide survey was administered to primary care physicians, endocrinologists, and cardiologists in a: (1) tertiary academic hospital, (2) community hospital, and (3) the American College of Physicians Insider Panel. Survey domains assessed non-alcoholic fatty liver disease knowledge, recommendations for screening, risk stratification, treatment, and referral patterns. RESULTS: A total of 440 providers completed the survey (35.2% completion rate; N = 82 academic hospital, N = 21 community hospital, N = 337 American College of Physicians). Half were male (51.7%), 78% from internal medicine, with 5% subspecialists. Providers were knowledgeable regarding prevalence and risk factors for non-alcoholic fatty liver disease. 58% would support screening for non-alcoholic fatty liver disease and used liver enzymes to do so. Only 22.5% used serum biomarkers and 23% used transient elastography for risk stratification. Primary reason for referral was advanced fibrosis/cirrhosis. 80% reported barriers to treating non-alcoholic fatty liver disease. There was no consistent diet recommended. CONCLUSION: In this nationwide survey, we demonstrated that while overall disease knowledge was good, there was an important disconnect between current guidelines and real-world clinical practice. There is also significant heterogeneity in practice patterns for first-line therapy of non-alcoholic fatty liver disease and the majority of provider’s report barriers to treating non-alcoholic fatty liver disease. These findings highlight the potential role for reevaluating screening and risk stratification recommendations in primary care to better align with needs in that setting. |
format | Online Article Text |
id | pubmed-8460969 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-84609692021-09-25 Primary care and referring physician perspectives on non-alcoholic fatty liver disease management: a nationwide survey Saeed, Naba Glass, Lisa M. Habbal, Heba Mahmood, Asad Sengstock, David Saini, Sameer D. Tincopa, Monica A. Therap Adv Gastroenterol Original Research INTRODUCTION: The optimal approach to screening and risk stratification for non-alcoholic fatty liver disease is challenging given disease burden and variable progression. The aim of this study was to assess primary care physician and referring physician practice patterns regarding non-alcoholic fatty liver disease. METHODS: An anonymous nationwide survey was administered to primary care physicians, endocrinologists, and cardiologists in a: (1) tertiary academic hospital, (2) community hospital, and (3) the American College of Physicians Insider Panel. Survey domains assessed non-alcoholic fatty liver disease knowledge, recommendations for screening, risk stratification, treatment, and referral patterns. RESULTS: A total of 440 providers completed the survey (35.2% completion rate; N = 82 academic hospital, N = 21 community hospital, N = 337 American College of Physicians). Half were male (51.7%), 78% from internal medicine, with 5% subspecialists. Providers were knowledgeable regarding prevalence and risk factors for non-alcoholic fatty liver disease. 58% would support screening for non-alcoholic fatty liver disease and used liver enzymes to do so. Only 22.5% used serum biomarkers and 23% used transient elastography for risk stratification. Primary reason for referral was advanced fibrosis/cirrhosis. 80% reported barriers to treating non-alcoholic fatty liver disease. There was no consistent diet recommended. CONCLUSION: In this nationwide survey, we demonstrated that while overall disease knowledge was good, there was an important disconnect between current guidelines and real-world clinical practice. There is also significant heterogeneity in practice patterns for first-line therapy of non-alcoholic fatty liver disease and the majority of provider’s report barriers to treating non-alcoholic fatty liver disease. These findings highlight the potential role for reevaluating screening and risk stratification recommendations in primary care to better align with needs in that setting. SAGE Publications 2021-09-20 /pmc/articles/PMC8460969/ /pubmed/34567270 http://dx.doi.org/10.1177/17562848211042200 Text en © The Author(s), 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Research Saeed, Naba Glass, Lisa M. Habbal, Heba Mahmood, Asad Sengstock, David Saini, Sameer D. Tincopa, Monica A. Primary care and referring physician perspectives on non-alcoholic fatty liver disease management: a nationwide survey |
title | Primary care and referring physician perspectives on non-alcoholic fatty liver disease management: a nationwide survey |
title_full | Primary care and referring physician perspectives on non-alcoholic fatty liver disease management: a nationwide survey |
title_fullStr | Primary care and referring physician perspectives on non-alcoholic fatty liver disease management: a nationwide survey |
title_full_unstemmed | Primary care and referring physician perspectives on non-alcoholic fatty liver disease management: a nationwide survey |
title_short | Primary care and referring physician perspectives on non-alcoholic fatty liver disease management: a nationwide survey |
title_sort | primary care and referring physician perspectives on non-alcoholic fatty liver disease management: a nationwide survey |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460969/ https://www.ncbi.nlm.nih.gov/pubmed/34567270 http://dx.doi.org/10.1177/17562848211042200 |
work_keys_str_mv | AT saeednaba primarycareandreferringphysicianperspectivesonnonalcoholicfattyliverdiseasemanagementanationwidesurvey AT glasslisam primarycareandreferringphysicianperspectivesonnonalcoholicfattyliverdiseasemanagementanationwidesurvey AT habbalheba primarycareandreferringphysicianperspectivesonnonalcoholicfattyliverdiseasemanagementanationwidesurvey AT mahmoodasad primarycareandreferringphysicianperspectivesonnonalcoholicfattyliverdiseasemanagementanationwidesurvey AT sengstockdavid primarycareandreferringphysicianperspectivesonnonalcoholicfattyliverdiseasemanagementanationwidesurvey AT sainisameerd primarycareandreferringphysicianperspectivesonnonalcoholicfattyliverdiseasemanagementanationwidesurvey AT tincopamonicaa primarycareandreferringphysicianperspectivesonnonalcoholicfattyliverdiseasemanagementanationwidesurvey |